KLF9 anticorps (N-Term)
Aperçu rapide pour KLF9 anticorps (N-Term) (ABIN2301731)
Antigène
Voir toutes KLF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 28-57, N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- KLF9, NT (KLF9, BTEB, BTEB1, Krueppel-like factor 9, GC-box-binding protein 1, Basic transcription element-binding protein 1, Transcription factor BTEB1)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- KLF9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 28-57 amino acids from the N-terminal region of human KLF9.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- KLF9 (Kruppel-Like Factor 9 (KLF9))
-
Autre désignation
- KLF9
-
NCBI Accession
- NP_001197
-
UniProt
- Q13886
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway
Antigène
-